-
1
-
-
0035865012
-
Cancer risk in patients with inflammatory bowel disease: A population-based study
-
DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z
-
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population based study. Cancer 2001; 91:854-862. (Pubitemid 32173312)
-
(2001)
Cancer
, vol.91
, Issue.4
, pp. 854-862
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Kliewer, E.3
Wajda, A.4
-
2
-
-
17644386242
-
Risk of haematopoietic cancer in patients with inflammatory bowel disease
-
DOI 10.1136/gut.2004.051771
-
Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Lö fberg R, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005; 54:617-622. (Pubitemid 40559243)
-
(2005)
Gut
, vol.54
, Issue.5
, pp. 617-622
-
-
Askling, J.1
Brandt, L.2
Lapidus, A.3
Karlen, P.4
Bjorkholm, M.5
Lofberg, R.6
Ekbom, A.7
-
3
-
-
27744520447
-
Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
-
DOI 10.1136/ard.2004.033241
-
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005; 64:1414-1420. PMCID: PMC1755232. (Pubitemid 41623850)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.10
, pp. 1414-1420
-
-
Askling, J.1
Fored, C.M.2
Baecklund, E.3
Brandt, L.4
Backlin, C.5
Ekbom, A.6
Sundstrom, C.7
Bertilsson, L.8
Coster, L.9
Geborek, P.10
Jacobsson, L.T.11
Lindblad, S.12
Lysholm, J.13
Rantapaa-Dahlqvist, S.14
Saxne, T.15
Klareskog, L.16
Feltelius, N.17
-
4
-
-
33644892763
-
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
-
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006; 54:692-701.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 692-701
-
-
Baecklund, E.1
Iliadou, A.2
Askling, J.3
Ekbom, A.4
Backlin, C.5
Granath, F.6
-
5
-
-
22644446331
-
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
-
DOI 10.1136/gut.2004.049460
-
Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54:1121-1125. PMCID: PMC1774897. (Pubitemid 41025906)
-
(2005)
Gut
, vol.54
, Issue.8
, pp. 1121-1125
-
-
Kandiel, A.1
Fraser, A.G.2
Korelitz, B.I.3
Brensinger, C.4
Lewis, J.D.5
-
6
-
-
67949112671
-
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: A meta-analysis
-
PMCID: PMC2846413
-
Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol 2009; 7:874-881. PMCID: PMC2846413.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 874-881
-
-
Siegel, C.A.1
Marden, S.M.2
Persing, S.M.3
Larson, R.J.4
Sands, B.E.5
-
7
-
-
13944252969
-
Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease
-
DOI 10.1097/00005176-200502000-00026
-
Thayu M, Markowitz JE, Mamula P, Russo PA, Muinos WI, Baldassano RN. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn's disease. J Pediatr Gastroenterol Nutr 2005; 40:220-222. (Pubitemid 40269746)
-
(2005)
Journal of Pediatric Gastroenterology and Nutrition
, vol.40
, Issue.2
, pp. 220-222
-
-
Thayu, M.1
Markowitz, J.E.2
Mamula, P.3
Russo, P.A.4
Muinos, W.I.5
Baldassano, R.N.6
-
8
-
-
33846592386
-
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
-
DOI 10.1097/MPG.0b013e31802f6424, PII 0000517620070200000019
-
Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44: 265-267. (Pubitemid 46175082)
-
(2007)
Journal of Pediatric Gastroenterology and Nutrition
, vol.44
, Issue.2
, pp. 265-267
-
-
Mackey, A.C.1
Green, L.2
Liang, L.-C.3
Dinndorf, P.4
Avigan, M.5
-
9
-
-
67650373290
-
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: Update
-
Mackey AC, Green L, Leptak C, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: Update. J Pediatr Gastroenterol Nutr 2009; 48:386-388.
-
(2009)
J Pediatr Gastroenterol Nutr
, vol.48
, pp. 386-388
-
-
MacKey, A.C.1
Green, L.2
Leptak, C.3
Avigan, M.4
-
10
-
-
34447534349
-
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy [1]
-
DOI 10.1080/10428190701345433, PII 780394996
-
Zeidan A, Sham R, Shapiro J, Baratta A, Kouides P. Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy. Leuk Lymphoma 2007; 48:1410-1413. (Pubitemid 47079370)
-
(2007)
Leukemia and Lymphoma
, vol.48
, Issue.7
, pp. 1410-1413
-
-
Zeidan, A.1
Sham, R.2
Shapiro, J.3
Baratta, A.4
Kouides, P.5
-
11
-
-
34347369156
-
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale?
-
DOI 10.1002/ibd.20169
-
Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 2007; 13:1024-1030. (Pubitemid 47309975)
-
(2007)
Inflammatory Bowel Diseases
, vol.13
, Issue.8
, pp. 1024-1030
-
-
Rosh, J.R.1
Gross, T.2
Mamula, P.3
Griffiths, A.4
Hyams, J.5
-
12
-
-
77950506382
-
S1133 hepatosplenic T-cell lymphoma (HSTCL) and inflammatory bowel disease (IBD): A rare complication after long-term thiopurine exposure: Case report and systematic review of the literature
-
Kotlyar D, Blonski W, Porter DL, Mendizabal M, Lin NV, Lichtenstein GR. S1133 hepatosplenic T-cell lymphoma (HSTCL) and inflammatory bowel disease (IBD): a rare complication after long-term thiopurine exposure: case report and systematic review of the literature. Gastroenterology 2009; 136:A-196-A-197.
-
(2009)
Gastroenterology
, vol.136
-
-
Kotlyar, D.1
Blonski, W.2
Porter, D.L.3
Mendizabal, M.4
Lin, N.V.5
Lichtenstein, G.R.6
-
13
-
-
56549085510
-
Hepatosplenic T cell lymphoma in inflammatory bowel disease
-
Shale M, Kanfer E, Panaccione R, Ghosh S. Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut 2008; 57:1639-1641.
-
(2008)
Gut
, vol.57
, pp. 1639-1641
-
-
Shale, M.1
Kanfer, E.2
Panaccione, R.3
Ghosh, S.4
-
14
-
-
56349126141
-
Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease
-
Drini M, Prichard PJ, Brown GJ, Macrae FA. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease. Med J Aust 2008; 189:464-465.
-
(2008)
Med J Aust
, vol.189
, pp. 464-465
-
-
Drini, M.1
Prichard, P.J.2
Brown, G.J.3
MacRae, F.A.4
-
15
-
-
78650239266
-
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease
-
Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2011; 9:36-41.
-
(2011)
Clin Gastroenterol Hepatol
, Issue.9
, pp. 36-41
-
-
Kotlyar, D.S.1
Osterman, M.T.2
Diamond, R.H.3
Porter, D.4
Blonski, W.C.5
Wasik, M.6
-
16
-
-
77954390990
-
Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: Case report and literature review
-
Ochenrider MG, Patterson DJ, Aboulafia DM. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review. Clin Lymphoma Myeloma Leuk 2010; 10:144-148.
-
(2010)
Clin Lymphoma Myeloma Leuk
, vol.10
, pp. 144-148
-
-
Ochenrider, M.G.1
Patterson, D.J.2
Aboulafia, D.M.3
-
17
-
-
77950988234
-
Infliximab azathioprine or combination therapy for Crohn's disease
-
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362:1383-1395.
-
(2010)
N Engl J Med
, vol.362
, pp. 1383-1395
-
-
Colombel, J.F.1
Sandborn, W.J.2
Reinisch, W.3
Mantzaris, G.J.4
Kornbluth, A.5
Rachmilewitz, D.6
-
18
-
-
70449100743
-
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study
-
Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374:1617-1625.
-
(2009)
Lancet
, vol.374
, pp. 1617-1625
-
-
Beaugerie, L.1
Brousse, N.2
Bouvier, A.M.3
Colombel, J.F.4
Lémann, M.5
Cosnes, J.6
-
19
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
DOI 10.1001/jama.295.19.2275
-
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275-2285. (Pubitemid 43736578)
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.19
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
Buchan, I.4
Matteson, E.L.5
Montori, V.6
-
20
-
-
1542725071
-
Epstein-Barr virus viral load in Crohn's disease: Effect of immunosuppressive therapy
-
DOI 10.1097/00054725-200403000-00004
-
Reijasse D, Le Pendeven C, Cosnes J, Dehee A, Gendre JP, Nicolas JC, et al. Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy. Inflamm Bowel Dis 2004; 10: 85-90. (Pubitemid 38332166)
-
(2004)
Inflammatory Bowel Diseases
, vol.10
, Issue.2
, pp. 85-90
-
-
Reijasse, D.1
Le Pendeven, C.2
Cosnes, J.3
Dehee, A.4
Gendre, J.-P.5
Nicolas, J.-C.6
Beaugerie, L.7
-
21
-
-
77957836758
-
Hepatosplenic T-cell lymphoma in inflammatory bowel disease: A possible thiopurine-induced chromosomal abnormality
-
Kotlyar DS, Blonski W, Diamond RH, Wasik M, Lichtenstein GR. Hepatosplenic T-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality. Am J Gastroenterol 2010; 105:2299-2301.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 2299-2301
-
-
Kotlyar, D.S.1
Blonski, W.2
Diamond, R.H.3
Wasik, M.4
Lichtenstein, G.R.5
-
22
-
-
66149096620
-
Hepatosplenic gamma-delta T-cell lymphoma: Clinicopathological features and treatment
-
Falchook GS, Vega F, Dang NH, Samaniego F, Rodriguez MA, Champlin RE, et al. Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 2009; 20:1080-1085.
-
(2009)
Ann Oncol
, vol.20
, pp. 1080-1085
-
-
Falchook, G.S.1
Vega, F.2
Dang, N.H.3
Samaniego, F.4
Rodriguez, M.A.5
Champlin, R.E.6
-
23
-
-
34250625241
-
Hepatosplenic and other gamma delta T-cell lymphomas
-
Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gamma delta T-cell lymphomas. Am J Clin Pathol 2007; 127:869-880.
-
(2007)
Am J Clin Pathol
, vol.127
, pp. 869-880
-
-
Vega, F.1
Medeiros, L.J.2
Gaulard, P.3
-
24
-
-
57649244342
-
Systematic review: Adverse event reports for oral sodium phosphate and polyethylene glycol
-
Belsey J, Epstein O, Heresbach D. Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther 2008; 29:15-28.
-
(2008)
Aliment Pharmacol Ther
, vol.29
, pp. 15-28
-
-
Belsey, J.1
Epstein, O.2
Heresbach, D.3
|